Wegovy study sparks high expectations: Novo Nordisk to reveal findings on cardiovascular benefits
The excitement is high before Novo Nordisk unveils detailed data from a large cardiovascular study with its successful weight loss drug Wegovy this weekend.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.